| Q35214557 | Advances in tenascin-C biology |
| Q33526253 | Application of gene network analysis techniques identifies AXIN1/PDIA2 and endoglin haplotypes associated with bicuspid aortic valve |
| Q33712168 | Differential expression of collagen type V and XI alpha-1 in human ascending thoracic aortic aneurysms |
| Q36160537 | Endogenous Reference Genes for Gene Expression Studies on Bicuspid Aortic Valve Associated Aortopathy in Humans |
| Q82297292 | Increased Expression of Tenascin-X in Thoracic and Abdominal Aortic Aneurysm Tissues |
| Q36927022 | Potential relationship between hepatobiliary osteopontin and peroxisome proliferator-activated receptor alpha expression following ethanol-associated hepatic injury in vivo and in vitro |
| Q34381768 | Rare copy number variants disrupt genes regulating vascular smooth muscle cell adhesion and contractility in sporadic thoracic aortic aneurysms and dissections |
| Q33632165 | Selection of reference genes for quantitative real time PCR (qPCR) assays in tissue from human ascending aorta |
| Q37024218 | Type A dissection and chronic dilatation: tenascin-C as a key factor in destabilization of the aortic wall |
| Q35876843 | Unraveling divergent gene expression profiles in bicuspid and tricuspid aortic valve patients with thoracic aortic dilatation: the ASAP study |
| Q35221374 | miR-30e targets IGF2-regulated osteogenesis in bone marrow-derived mesenchymal stem cells, aortic smooth muscle cells, and ApoE-/- mice |